TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cizzle Biotechnology Holdings PLC ( (GB:CIZ) ) has provided an update.
Cizzle Biotechnology Holdings PLC has announced a change in its registered office and UK head office to Level 19, The Shard, London, effective immediately. This strategic move could potentially enhance the company’s operational efficiency and visibility within the industry, benefiting stakeholders and reinforcing its market presence in early cancer diagnostics.
More about Cizzle Biotechnology Holdings PLC
Cizzle Biotechnology Holdings PLC is a UK-based diagnostics company specializing in the development of early cancer detection tests. The company has developed a non-invasive, cost-effective blood test using the CIZ1B biomarker, which is associated with early-stage lung cancer. Cizzle has entered into commercial royalty-bearing licensing agreements and collaborations with cancer care centers, and was listed on the London Stock Exchange in May 2021.
Average Trading Volume: 1,367,357
Technical Sentiment Signal: Sell
Current Market Cap: £5.11M
For a thorough assessment of CIZ stock, go to TipRanks’ Stock Analysis page.